학술논문
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs
Document Type
Article
Author
Source
In: Clinical and Experimental Rheumatology . (Clinical and Experimental Rheumatology, March 2023, 41(3):667-675)
Subject
Language
English
ISSN
1593098X
0392856X
0392856X